PERSPECTA

News from every angle

← Back to headlines

Arcutis Biotherapeutics Spotlights ZORYVE Surge, 2025 Revenue Beat and Key FDA Milestones at TD Cowen

4 Mar, 13:09 — 4 Mar, 13:09
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

Yahoo8h ago

Arcutis Biotherapeutics Spotlights ZORYVE Surge, 2025 Revenue Beat and Key FDA Milestones at TD Cowen

Read full article →

Related Stories

Beware of fake HIV test kits in circulation, NAFDAC warns Nigerians

46m ago

Italy-Argentina sign memorandum of understanding on health matters

48m ago

Heavier cases for the eating disorder team and faster illnesses

53m ago

8 most common misconceptions about proteins and what science says

59m ago